a another vaccine is in development: it consists in directly inoculating the parasite in people and, immediately following, giving them an antimalarial therapy. It performed well in a small clinical trial involving 56 people, reported in the journal Nature. However, the results of a larger clinical trial must be awaited currently underway in Mali
